Target intelligence / Profile preview

Porcine reproductive and respiratory syndrome virus (PRRSV) (PRRSV)

Target
PRRSV
Molecular classification
Virus, Arteriviridae, Positive-sense ssRNA virus
01

Overview

Porcine reproductive and respiratory syndrome virus (PRRSV) is a small, enveloped, single-stranded positive-sense RNA virus that belongs to the family Arteriviridae and is the causative agent of PRRS in swine (Lunney et al., 2016). The virus primarily targets porcine alveolar macrophages, utilizing host receptors such as CD163 and SIGLEC1 for attachment and internalization (Zhang and Yoo, 2015). Immune system activation occurs when the host recognizes viral antigens, particularly the major envelope glycoprotein 5 (GP5), the membrane protein (M), and the nucleocapsid protein (N), which are critical for inducing neutralizing antibodies and T-cell responses (Du et al., 2017). However, PRRSV is notorious for its ability to evade the host immune system through mechanisms like glycan shielding and the inhibition of type I interferon production, leading to delayed and often ineffective immune clearance (Sun et al., 2018). Vaccines, including modified live virus (MLV) and inactivated versions, aim to prime the immune system against these antigens, but their efficacy is often limited by the high genetic diversity of the virus and the risk of antibody-dependent enhancement (Nan et al., 2017).

Other names
Lelystad virusBlue-ear pig disease virusSwine infertility and respiratory syndrome virusPRRSV-1PRRSV-2
02

Mechanism of action

Induction of humoral and cellular immune responses through the presentation of viral structural antigens (GP5, M, N) to host lymphocytes to generate neutralizing antibodies and T-cell immunity.

03

Biological functions

Viral replicationHost cell entryImmune evasionInduction of apoptosisCytokine modulation
04

Disease associations

Porcine reproductive and respiratory syndromeInfectionReproductive failureRespiratory disease
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral recombination between vaccine and wild-type strainsPersistent infection and sheddingImmunosuppression
06

Interacting drugs

Ingelvac PRRS MLV

4 more in the full profile.

07

Biomarkers

PRRSV-specific IgG antibodiesViral RNA (ORF7)CD163 expression levelsIFN-gamma secreting cells

Beyond the preview

Go deeper on Porcine reproductive and respiratory syndrome virus (PRRSV) (PRRSV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porcine reproductive and respiratory syndrome virus (PRRSV) (PRRSV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call